Home›Signals›Clinical Trial Activity
■

Clinical Trial Activity

Active clinical trials by phase and status

50 Active Signals
SYNHSyneos HealthCRO Biopharmaceutical
SGENSeagen IncOncology ADC
GILDGilead SciencesAntiviral
C
52/100
BIIBBiogen IncNeuroscience
C
51/100
EXELExelixis IncOncology
C
54/100
ITCIIntra-Cellular TherapiesNeuroscience
C
63/100
VRTXVertex PharmaceuticalsGene Therapy
C
61/100
XENEXenon PharmaceuticalsIon Channel CNS
C
55/100
RGNXREGENXBIO IncGene Therapy
C
61/100
IOVAIovance BiotherapeuticsCell Therapy
C
57/100
NVSNovartis AGDiversified Pharma
C
51/100
DCPHDeciphera PharmaceuticalsOncology
C
63/100
UTHRUnited TherapeuticsPulmonary
C
53/100
INCYIncyte CorporationOncology
C
52/100
BMRNBioMarin PharmaceuticalRare Disease
C
53/100
YMABY-mAbs TherapeuticsPediatric Oncology
C
63/100
ARVNArvinas IncProtein Degradation
C
55/100
RAREUltragenyx PharmaceuticalRare Disease
C
60/100
BNTXBioNTech SEmRNA Therapeutics
C
53/100
FDMT4D Molecular Therapeutics, Inc.Biotech / Pharma
C
58/100
ASNDAscendis PharmaRare Endocrine
C
53/100
RIGLRigel PharmaceuticalsImmunology
C
56/100
ALNYAlnylam PharmaceuticalsRNAi Therapeutics
C
53/100
MRNAModerna IncmRNA Therapeutics
C
59/100
IBRXImmunityBio, Inc.Biotech / Pharma
C
58/100
JAZZJazz Pharmaceuticals plcBiotech / Pharma
C
52/100
IDYAIDEAYA BiosciencesPrecision Oncology
C
56/100
RVMDRevolution MedicinesPrecision Oncology
C
52/100
AXSMAxsome TherapeuticsNeuroscience
D
38/100
IONSIonis PharmaceuticalsAntisense Therapeutics
C
55/100
AGENAgenus IncImmuno-Oncology
C
64/100
AMGNAmgen IncBiologics
C
52/100
TOIThe Oncology Institute, Inc.Oncology
C
61/100
KURAKura Oncology, Inc.Oncology
C
61/100
ISRGIntuitive Surgical, Inc.Biotech / Pharma
F
15/100
UCBNVUCB SANeurology Immunology
C
63/100
ICLRICON plcCRO Clinical Research
C
51/100
DXCMDexCom IncDiabetes Tech
F
17/100
NTRANatera IncGenetics Diagnostics
C
52/100
SNDXSyndax PharmaceuticalsOncology
C
58/100
ARWRArrowhead PharmaceuticalsRNAi Therapeutics
C
53/100
MIRMMirum PharmaceuticalsLiver Disease
C
56/100
TVTXTravere TherapeuticsNephrology
C
60/100
ARGXargenx SEAutoimmune
C
52/100
NVONovo NordiskDiabetes/Obesity
C
51/100
BAYRYBayer AGPharma/Crop Science
C
56/100
SNYSanofi SAImmunology
C
51/100
AZNAstraZenecaOncology/Respiratory
C
51/100
MRKMerck & CoOncology/Vaccines
C
52/100
PFEPfizer IncDiversified Pharma
C
52/100
Not financial advice. BiotechSign data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.
© 2026 BiotechSign — AI-powered biotech catalyst intelligence